Also, further pre-clinical studies are needed to evaluate whether the link between SIRT7-JNK and Akt-dependent de novo lipid synthesis, required for increased proliferation and survival of PAH PAVSMC, could be a potential target pathway for therapeutic intervention. The gene discussed is AKT1; the disease is pulmonary arterial hypertension.